480k Funding from Innosuisse
ELIONOVA, Haute école d’ingénierie et d’architecture and University of Fribourg, receive 480k funding from Innosuisse, the Swiss Innovation Agency for a joint project to develop a comprehensive blood test for sepsis.

With a significant contribution for the development in the Medtech industry, Haute école d’ingénierie et d’architecture and University of Fribourg together with  ELIONOVA as an implementation partner have received a substantial grant of CHF 480’000 for the Research Partners. Innosuisse supports SMEs, startups and other Swiss organizations in their R&D activities. With the acquired funding, ELIONOVA continues the development of its EVA technology and aims to expand its technology into further markets. Elionova’s rapid assay technology (quantitative results in 10 minutes) at the point of emergency e.g. the emergency sites of hospitals and thereby improve the early detection of septic patients, a key to more efficient treatment.

Odoo • Text and Image
Elionova founded